Qianren Pharmaceutical
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $14M
Investors
- 2
About Qianren Pharmaceutical
, doing business as Qianren Pharmaceutical, is a pharmaceutical company integrating research, development, production and sales. To date, the company employs over 200 people, including more than 100 people working in R&D. It has established a drug research center and collaborates with renowned domestic universities and research institutes in China. Qianren Pharmaceutical mainly engages in the research, development, production, and sales of cardiovascular, respiratory, digestive, anti-tumor, and anti-diabetic drugs. The company's main products include Sitagliptin Metformin Extended-Release Tablets, Eperisone Hydrochloride Tablets, Mesalazine Enteric-Coated Tablets, etc. The company generates revenues from providing pharmaceutical products.
Who invested in Qianren Pharmaceutical
2 investors across 2 rounds
See all investors in Qianren Pharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Qianren Pharmaceutical
Who invested in Qianren Pharmaceutical?
Qianren Pharmaceutical has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qianren Pharmaceutical raised?
Qianren Pharmaceutical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Qianren Pharmaceutical last raise money?
Qianren Pharmaceutical's most recent round on record is a Series A, in Dec 2025.
What does Qianren Pharmaceutical do?
, doing business as Qianren Pharmaceutical, is a pharmaceutical company integrating research, development, production and sales.
Where is Qianren Pharmaceutical headquartered?
Qianren Pharmaceutical is headquartered in Lianyungang, China.
Which VCs invest in companies like Qianren Pharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Qianren Pharmaceutical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Qianren Pharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.